Cargando…

Effects of imipenem combined with low-dose cyclophosphamide on the intestinal barrier in septic rats

Anti-infection therapy combined with immunotherapy is one of the important research approaches for treating sepsis. However, the combination of anti-infection and immunotherapy therapeutic agents may have an adverse effect on intestinal barrier function. In the present study, it was hypothesized tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Peng, Zhang, Shun-Wen, Zhang, Jie, Dong, Jiang-Tao, Wu, Jiang-Dong, Tang, Su-Tu, Yang, Jun-Ting, Zhang, Wan-Jiang, Wu, Fang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2018
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6122399/ https://www.ncbi.nlm.nih.gov/pubmed/30186419 http://dx.doi.org/10.3892/etm.2018.6373

Ejemplares similares

Gadolinium chloride pre-treatment reduces the inflammatory response and preserves intestinal barrier function in a rat model of sepsis
por: Zhao, Yan Heng, et al.
Publicado: (2021)

Comparison of mono- and combination antibiotic therapy for the treatment of Pseudomonas aeruginosa bacteraemia: A cumulative meta-analysis of cohort studies
por: Tang, Su Yu, et al.
Publicado: (2018)

Effects of Caulis Spatholobi Polysaccharide on Immunity, Intestinal Mucosal Barrier Function, and Intestinal Microbiota in Cyclophosphamide-Induced Immunosuppressive Chickens
por: Cui, Yao, et al.
Publicado: (2022)

Intrapulmonary Pharmacokinetics of Relebactam, a Novel β-Lactamase Inhibitor, Dosed in Combination with Imipenem-Cilastatin in Healthy Subjects
por: Rizk, Matthew L., et al.
Publicado: (2018)

Appropriateness of empiric antimicrobial therapy with imipenem/colistin in severe septic patients: observational cohort study
por: Trifi, Ahlem, et al.
Publicado: (2018)

Emodin Ameliorates Intestinal Dysfunction by Maintaining Intestinal Barrier Integrity and Modulating the Microbiota in Septic Mice
por: Zhang, Mina, et al.
Publicado: (2022)

Intestinal mucosal barrier in functional constipation: Dose it change?
por: Wang, Jun-Ke, et al.
Publicado: (2022)

Comparable Effect of Two-Step Versus Extended Infusions on the Pharmacokinetics of Imipenem in Patients with Sepsis and Septic Shock
por: Huang, Yingzi, et al.
Publicado: (2020)

Genomic Characterization of Imipenem- and Imipenem-Relebactam-Resistant Clinical Isolates of Pseudomonas aeruginosa
por: López-Pérez, Mario, et al.
Publicado: (2021)

Activity of imipenem/relebactam on Klebsiella pneumoniae with different mechanisms of imipenem non-susceptibility
por: Mashaly, Mervat El-Sayed, et al.
Publicado: (2021)

Effect of Alemtuzumab on Intestinal Intraepithelial Lymphocytes and Intestinal Barrier Function in Cynomolgus Model
por: Qu, Lin-Lin, et al.
Publicado: (2015)

Umbilical cord mesenchymal stem cells enhance the therapeutic effect of imipenem by regulating myeloid-derived suppressor cells in septic mice
por: Long, Xianming, et al.
Publicado: (2021)

Effect of high-dose melphalan on marrow and intestinal epithelium in mice pretreated with cyclophosphamide.
por: Millar, J. L., et al.
Publicado: (1978)

The synergetic effect of Imipenem-clarithromycin combination in the Mycobacteroides abscessus complex
por: Takei, Satomi, et al.
Publicado: (2020)

Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
por: Lopeman, Rose C., et al.
Publicado: (2020)

Upstream region of OprD mutations in imipenem-resistant and imipenem-sensitive Pseudomonas isolates
por: Kiani, Masoumeh, et al.
Publicado: (2021)

In vitro studies evaluating the activity of imipenem in combination with relebactam against Pseudomonas aeruginosa
por: Young, Katherine, et al.
Publicado: (2019)

Evaluation of the appropriateness of imipenem/cilastatin prescription and dosing in a tertiary care hospital
por: Kabbara, Wissam K, et al.
Publicado: (2015)

Population-Based Pharmacokinetics and Dose Optimization of Imipenem in Vietnamese Critically-Ill Patients
por: Dinh, Thanh D, et al.
Publicado: (2022)

Polysaccharides From the Roots of Millettia Speciosa Champ Modulate Gut Health and Ameliorate Cyclophosphamide-Induced Intestinal Injury and Immunosuppression
por: Chen, Xiaogang, et al.
Publicado: (2021)

Immunological responses of septic rats to combination therapy with thymosin α1 and vitamin C
por: Zhang, Daquan, et al.
Publicado: (2023)

Function of capric acid in cyclophosphamide-induced intestinal inflammation, oxidative stress, and barrier function in pigs
por: Lee, Sang In, et al.
Publicado: (2017)

Cyclophosphamide priming reduces intestinal damage in man following high dose melphalan chemotherapy.
por: Selby, P. J., et al.
Publicado: (1987)

Systematic evaluation of different doses of cyclophosphamide induction therapy for lupus nephritis
por: Tian, Ming, et al.
Publicado: (2017)

Reduced lethality in mice receiving a combined dose of cyclophosphamide and busulphan.
por: Millar, J. L., et al.
Publicado: (1975)

A call for better understanding the role of albumin in mediating VE-cadherin phosphorylation and endothelial barrier dysfunction in septic patients
por: Li, Yupei, et al.
Publicado: (2021)

Mechanisms of Heteroresistance and Resistance to Imipenem in Pseudomonas aeruginosa
por: Xu, Ye, et al.
Publicado: (2020)

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacterial Infections
por: Brown, Michelle, et al.
Publicado: (2018)

Evaluation of Renal Safety Between Imipenem/Relebactam and Colistin Plus Imipenem in Patients With Imipenem-Nonsusceptible Bacterial Infections in the Randomized, Phase 3 RESTORE-IMI 1 Study
por: Brown, Michelle L, et al.
Publicado: (2020)

Imipenem Resistance Mediated by bla(OXA-913) Gene in Pseudomonas aeruginosa
por: Moon, Dong-Chan, et al.
Publicado: (2021)

Allicin Improves Intestinal Epithelial Barrier Function and Prevents LPS-Induced Barrier Damages of Intestinal Epithelial Cell Monolayers
por: Gao, Jingxia, et al.
Publicado: (2022)

Pharmacokinetics, Safety, and Tolerability of Single and Multiple Doses of Relebactam, a β-Lactamase Inhibitor, in Combination with Imipenem and Cilastatin in Healthy Participants
por: Rhee, Elizabeth G., et al.
Publicado: (2018)

Protective Effect of Ursolic Acid on the Intestinal Mucosal Barrier in a Rat Model of Liver Fibrosis
por: Zhang, Wang, et al.
Publicado: (2019)

Effect of Porcine Clostridium perfringens on Intestinal Barrier, Immunity, and Quantitative Analysis of Intestinal Bacterial Communities in Mice
por: Jiang, Zipeng, et al.
Publicado: (2022)

Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report
por: Zhang, Lingshu, et al.
Publicado: (2023)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
por: Khan, O A, et al.
Publicado: (2011)

Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
por: Khan, O A, et al.
Publicado: (2011)

Pharmacokinetics of Carboplatin in Combination with Low-Dose Cyclophosphamide in Female Dogs with Mammary Carcinoma
por: Machado, Marília Carneiro, et al.
Publicado: (2022)

Partial Enteral Nutrition Mitigated Ischemia/Reperfusion-Induced Damage of Rat Small Intestinal Barrier
por: Wu, Chao, et al.
Publicado: (2016)

Author Correction: Effect of Amoxicillin in combination with Imipenem-Relebactam against Mycobacterium abscessus
por: Lopeman, Rose C., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7k8rc5kdh65ai5niiob0gi6mmr